04/24/2024
5:17 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
5:18 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
6:22 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
6:23 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
5:40 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
5:42 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
4:36 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/10/2024
4:39 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:14 PM | Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
03/27/2024
6:37 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
5:47 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
5:48 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
8:50 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
8:51 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
4:08 PM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/15/2024
6:52 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
6:55 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
11:56 AM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
7:21 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:17 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:04 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:08 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
11:08 AM | Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Tanimoto Sarina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
10:45 AM | Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Lowenthal Richard E (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:35 AM | Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/04/2024
3:53 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:41 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Chakma Justin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:42 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Dorsey Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:45 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:47 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Karas Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
3:02 PM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
3:30 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
3:30 PM | Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
09/25/2023
3:17 PM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
5:05 AM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
7:04 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:15 PM | Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Bell Robert G. (Filed by)
| Form SC 13D/A | |
09/01/2023
12:46 PM | Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/31/2023
4:25 PM | Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D | |
08/31/2023
4:26 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
ORBIMED CAPITAL LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2023
4:26 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad) Central Banks Buying Gold in Record Numbers
Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). |
08/31/2023
4:18 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
5:03 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
7:16 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
7:55 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
1:12 PM | Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2023
8:00 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Islam Saqib (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
8:00 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
SCHNEIDER PHILLIP M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
8:00 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
SAUNDERS BRENT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
8:00 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
8:00 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
8:00 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shah Pratik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
8:00 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Kelly Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
8:00 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
8:03 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Dadoo Rajeev (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
3:32 PM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
6:48 PM | Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
4:07 PM | Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2023
3:31 PM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
8:03 AM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
8:05 AM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
8:12 AM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
11:15 PM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form EFFECT | |
05/01/2023
3:41 PM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form ARS | |
05/01/2023
3:30 PM | Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
